Product Images Miplyffa
View Photos of Packaging, Labels & Appearance
- Chemical Structure - mip00 0001 01
- Figure 1 - mip00 0001 02
- Figure A - mip00 0001 03
- Figure B - mip00 0001 04
- Figure C - mip00 0001 05
- Figure D - mip00 0001 06
- Figure E - mip00 0001 07
- Figure F - mip00 0001 08
- Figure G - mip00 0001 09
- Figure H - mip00 0001 10
- Figure I - mip00 0001 11
- Figure J - mip00 0001 12
- Figure K - mip00 0001 13
- Principal Display Panel – 47 mg Carton Label - mip00 0001 14
- Principal Display Panel – 62 mg Carton Label - mip00 0001 15
- Principal Display Panel – 93 mg Carton Label - mip00 0001 16
- Principal Display Panel – 124 mg Carton Label - mip00 0001 17
Product Label Images
The following 17 images provide visual information about the product associated with Miplyffa NDC 72542-147 by Acer Therapeutics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - mip00 0001 01
Figure 1 - mip00 0001 02
Mean change from baseline in RIDNPCCSS over time is being evaluated for two groups - one group receiving MIPLYFFA with miglustat and the other group receiving Placebo with miglustat. The data shows the progression of the mean change in RIDNPCCSS scores over a span of 12 months for both groups.*
Figure A - mip00 0001 03
Figure B - mip00 0001 04
Figure C - mip00 0001 05
Figure D - mip00 0001 06
Figure E - mip00 0001 07
Figure F - mip00 0001 08
Figure G - mip00 0001 09
Figure H - mip00 0001 10
Figure I - mip00 0001 11
Figure J - mip00 0001 12
Figure K - mip00 0001 13
Principal Display Panel – 47 mg Carton Label - mip00 0001 14
This is a product label for "IMPLIFYFFA" capsules (arimoclomol) containing 90 capsules for oral use. Each capsule contains 47 mg of arimoclomol equivalent to 75 mg of arimoclomol citrate. The recommended dosage is specified in the prescribing information. The capsules should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised to store the capsules in the original container, protect from light, and keep out of reach of children. The product is manufactured for Zevra Therapeutics, Inc. in Celebration, FL, USA.*
Principal Display Panel – 62 mg Carton Label - mip00 0001 15
This text provides information about arimoclomol capsules in 62mg strength and a package containing 90 capsules for oral use. It includes the recommended dosage, storage instructions, and manufacturer details. The capsules contain arimoclomol citrate and are for prescription use only.*
Principal Display Panel – 93 mg Carton Label - mip00 0001 16
This text provides information about a prescription medication called "MIPLYFFA" (arimoclomol) capsules. It includes details such as the recommended dosage, storage instructions, active ingredients, and package size. The medication is indicated for oral use and is available in a container with a child-resistant package. It is important to refer to the prescribing information before use.*
Principal Display Panel – 124 mg Carton Label - mip00 0001 17
This text appears to be a description of a medication called "IMIPLYFFA" (arimoclomol) capsules. It includes information such as the dosage, active ingredients, storage instructions, manufacturer details, and the fact that it is for oral use. The recommended dosage and storage conditions are also provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
